Press Release

Read more about the article GTNF 2023: Polosa at the conference in Seoul, South Korea

GTNF 2023: Polosa at the conference in Seoul, South Korea

β€œπ‘Šπ‘’ 𝑛𝑒𝑒𝑑 π‘‘π‘œ π‘π‘œπ‘™π‘™π‘Žπ‘π‘œπ‘Ÿπ‘Žπ‘‘π‘’ π‘‘π‘œπ‘”π‘’π‘‘β„Žπ‘’π‘Ÿ π‘ π‘œ π‘‘β„Žπ‘Žπ‘‘ π‘’π‘£π‘’π‘Ÿπ‘¦ 𝑠𝑖𝑛𝑔𝑙𝑒 π‘Žπ‘Ÿπ‘‘π‘–π‘π‘™π‘’ π‘π‘’π‘π‘œπ‘šπ‘’π‘  π‘Žπ‘› π‘’π‘‘π‘’π‘π‘Žπ‘‘π‘–π‘œπ‘›π‘Žπ‘™ π‘‘π‘œπ‘œπ‘™. π‘Šπ‘’ π‘‘π‘œπ‘›'𝑑 π‘€π‘Žπ‘›π‘‘ π‘‘π‘œ π‘π‘’π‘›π‘–π‘ β„Ž π‘Žπ‘’π‘‘β„Žπ‘œπ‘Ÿπ‘  π‘“π‘œπ‘Ÿ π‘‘β„Žπ‘’π‘–π‘Ÿ π‘—π‘’π‘›π‘˜ π‘π‘Žπ‘π‘’π‘Ÿπ‘ , 𝑀𝑒 π‘€π‘Žπ‘›π‘‘ π‘‘π‘œ π‘π‘Ÿπ‘œπ‘£π‘–π‘‘π‘’ π‘‘β„Žπ‘’ π‘ π‘œπ‘™π‘’π‘‘π‘–π‘œπ‘› π‘‘π‘œ π‘–π‘šπ‘π‘Ÿπ‘œπ‘£π‘’β€

Continue ReadingGTNF 2023: Polosa at the conference in Seoul, South Korea
Read more about the article Bari, Polosa: β€œRisk reduction to fight atherosclerosis”

Bari, Polosa: β€œRisk reduction to fight atherosclerosis”

β€œHowever, it is important to understand a fact when talking about smoking: even today, nicotine is believed to play a major role in the developing of atherosclerosis” explains prof. Polosa β€œNicotine does not cause atherosclerosis. In a survey conducted by SERMO on 1000 Italian doctors, it was found that 62 percent of the sample still think that atherosclerosis is caused by nicotine. The fact that 33 percent of the sample is made up of cardiologists is significant".

Continue ReadingBari, Polosa: β€œRisk reduction to fight atherosclerosis”
Read more about the article Cochrane: Some medicines and e-cigarettes can help people to quit smoking

Cochrane: Some medicines and e-cigarettes can help people to quit smoking

According the authors, for every 100 people, 10 to 19 are likely to quit using an e-cigarette; 12 to 16 using varenicline; and 10 to 18 using cytisine. This is compared to the 6 in 100 people likely to quit when using no medicine/e-cigarette or placebo. People using two forms of nicotine replacement therapy at the same time, for example, a combination of nicotine patch and nicotine gum, seemed to have similar rates of quitting to people using e-cigarettes, varenicline and cytisine.

Continue ReadingCochrane: Some medicines and e-cigarettes can help people to quit smoking
Read more about the article Letter to the Editors of Substance Abuse: vaping and youths researches

Letter to the Editors of Substance Abuse: vaping and youths researches

According to prof. Riccardo Polosa, CoEHAR founder: "This small qualitative research simply found what we already knew: that young people are eager to explore new experiences, withΒ vaping potentially being one of them. A critical limitation of this research is the absence of insights into how these participants have been educated about the health implications and addictive nature of nicotine/vaping. To work towards a smoke-free world, it's essential that our messaging on vaping's risk-to-benefit ratio is both accurate and truthful"

Continue ReadingLetter to the Editors of Substance Abuse: vaping and youths researches
Read more about the article CoEHAR advocate for e-liquids regulation: first ever reported urticaria case associate with vapingΒ 

CoEHAR advocate for e-liquids regulation: first ever reported urticaria case associate with vapingΒ 

For the first time, CoEHAR researches reported a case of urticaria following the inhalation of a specific flavoring in an e-liquid used during a switching trial. Although linked to a specific component of the liquid used, this finding highlight the need of further regulation of e-liquid.

Continue ReadingCoEHAR advocate for e-liquids regulation: first ever reported urticaria case associate with vapingΒ 
Read more about the article Atherosclerosis and smoking: Polosa at the SISA national conference

Atherosclerosis and smoking: Polosa at the SISA national conference

The conference will bring together leading experts in the field to discuss the latest research on dyslipidemias and their management. Topics to be covered include the latest guidelines from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), as well as innovative topics such as environmental risk factors, including smoking, and their role in the progression of atherosclerosis.

Continue ReadingAtherosclerosis and smoking: Polosa at the SISA national conference